About Triangle Pharmaceuticals
Triangle Pharmaceuticals is a company based in Staten Island (United States) founded in 1994 was acquired by Alcami in January 2020. Triangle Pharmaceuticals has raised $135.2 million across 4 funding rounds from investors including Gilead, Abbott and Alcami. Triangle Pharmaceuticals offers products and services including Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage. Triangle Pharmaceuticals operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
- Headquarter Staten Island, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alcami Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$135.2 M (USD)
in 4 rounds
-
Latest Funding Round
$58.2 M (USD), Private Equity Round
Mar 13, 2001
-
Investors
Gilead
& 3 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Triangle Pharmaceuticals
Triangle Pharmaceuticals offers a comprehensive portfolio of products and services, including Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage.
Offers sterile and oral solid dose production for pharmaceuticals.
Provides testing and method development for pharma and biologics.
Delivers secure cGMP storage with calibration and validation.
Funding Insights of Triangle Pharmaceuticals
Triangle Pharmaceuticals has successfully raised a total of $135.2M across 4 strategic funding rounds. The most recent funding activity was a Private Equity Round of $58.2 million completed in March 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Triangle Pharmaceuticals
Triangle Pharmaceuticals has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Gilead, Abbott and Alcami.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Locked | Locked | Locked | |
|
Developer of medical devices, generic pharmaceuticals, and nutrition products
|
Locked | Locked | Locked | |
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
Locked | Locked | Locked |
Investor details for Triangle Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Triangle Pharmaceuticals
Investment portfolio details for Triangle Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Triangle Pharmaceuticals
Detailed financials for Triangle Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Triangle Pharmaceuticals Comparisons
Peer comparison for Triangle Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Triangle Pharmaceuticals
Triangle Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Developer of biologics to treat hepatitis B infection
|
|
| Locked | Locked | Locked |
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
Detailed competitors of Triangle Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Triangle Pharmaceuticals
Complete news archive for Triangle Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Triangle Pharmaceuticals
Triangle Pharmaceuticals was founded in 1994 and raised its 1st funding round 1 year after it was founded.
Triangle Pharmaceuticals is headquartered in Staten Island, United States. It is registered at Staten Island, New York, United States.
Triangle Pharmaceuticals is a funded company, having raised a total of $135.2M across 4 funding rounds to date.
Triangle Pharmaceuticals was a specialty pharmaceutical company was developing antiviral drug candidates with a particular focus on therapies for the HIV and the hepatitis B virus. Its lead product Coviracil, a nucleoside reverse transcriptase inhibitor was in Phase 3 trials for the treatment of HIV. It was also developing Amdoxovir, a guanosine nucleoside analog for HIV and Clevudine, a pyrimidine nucleoside analog for chronic Hepatitis B. In December 2002, Gilead acquired Triangle Pharmaceuticals for 464M.
Triangle Pharmaceuticals's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
Triangle Pharmaceuticals offers Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage.